Clinical Outcomes clinical trials

Explore recruiting clinical outcomes clinical trials.

Recruiting clinical outcomes studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Clinical Outcomes trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Efficacy and safety of co-administered cagrilintide and semaglutide (CagriSema) once weekly versus placebo in participants with type 2 diabetes and painful diabetic peripheral neuropathy

Norway, Denmark, Spain, France

Therapeutic exploratory (Phase II) EU CTIS Study details

EvaluaTion of Clinical and laboratory outcomes of Rivaroxaban in short Bowel syndrome patients dEpending on Long term parenteral nutrition: a prospective cohort study (TINCRBEL study)

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

AN EXPLORATORY, MULTICENTER, RANDOMIZED,DOUBLE BLIND STUDY OF CLINICAL OUTCOMES,TOLERABILITY, AND SAFETY OF 2 DOSES OF ORAL PANTOPRAZOLE IN PEDIATRIC PARTICIPANTS AGED 1 TO 11 YEARS AND 12 TO 17 YEARS WHO REQUIRE MAINTENANCE THERAPY FOR HEALED EROSIVE ESOPHAGITIS

Slovakia, Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

Cohort study of human mpox virus disease

Belgium, Portugal, Italy, Spain, Norway, France +2 more

Therapeutic use (Phase IV) EU CTIS Study details

The Acute and Long-term Impact of Support and Music in Psilocybin Therapy for Depression: The Psilocybin Setting Trial (PSISET)

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Iceland Screens Treats or Prevents Multiple Myeloma (iStopMM): A nationwide phase 2 trial of patients with smoldering and active multiple myeloma (MM)

Iceland

Therapeutic exploratory (Phase II) EU CTIS Study details

Clinical Outcomes trials by city

Clinical Outcomes in Toronto Clinical Outcomes in Vancouver Clinical Outcomes in Montreal Clinical Outcomes in Calgary Clinical Outcomes in Edmonton Clinical Outcomes in Ottawa Clinical Outcomes in Winnipeg Clinical Outcomes in Quebec City Clinical Outcomes in Hamilton Clinical Outcomes in Kitchener Clinical Outcomes in London Clinical Outcomes in Halifax Clinical Outcomes in New York Clinical Outcomes in Los Angeles Clinical Outcomes in Chicago Clinical Outcomes in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease